. 2023 Sep 19;24(18):14292. doi: 10.3390/ijms241814292

Table A2.

Search Queries for the literature search of the meta-analysis from the examined databases.

Database	Query
PubMed	(“heart failure with preserved ejection fraction” OR “HFpEF” OR “E/A” OR “E/e” OR “E/e” OR “tissue doppler” OR “peak atrial longitudinal strain” OR “PALS” OR “atrial longitudinal strain rate” OR “left atrial strain” OR “left atrial stiffness” OR “left atrial” OR “left atrial volume” OR “left atrial volume index” OR “LAVi” OR “left atrial diameter” OR “diastolic dysfunction” OR “diastolic heart failure” OR “diastolic impairment” OR “diastolic”) AND (“nonalcoholic fatty liver disease” OR “non-alcoholic fatty liver disease” OR “NAFLD” OR “metabolic dysfunction fatty liver disease” OR “MAFLD” OR “fatty liver” OR “fatty liver disease” OR “steatosis” OR “liver steatosis” OR “hepatic steatosis” OR “steatohepatitis” OR “nonalcoholic steatohepatitis” OR “non-alcoholic steatohepatitis” OR “NASH”)
Embase	(‘heart failure with preserved ejection fraction’ OR HFpEF OR E/A OR E/e OR E/e' OR ‘tissue doppler’ OR ‘peak atrial longitudinal strain’ OR PALS OR ‘atrial longitudinal strain rate’ OR ‘left atrial strain’ OR ‘left atrial stiffness’ OR ‘left atrial’ OR ‘left atrial volume’ OR ‘left atrial volume index’ OR LAVi OR ‘left atrial diameter’ OR ‘diastolic dysfunction’ OR ‘diastolic heart failure’ OR ‘diastolic impairment’ OR diastolic) AND (‘nonalcoholic fatty liver disease’ OR ‘non-alcoholic fatty liver disease’ OR NAFLD OR ‘metabolic dysfunction fatty liver disease’ OR MAFLD OR ‘fatty liver’ OR ‘fatty liver disease’ OR steatosis OR ‘liver steatosis’ OR ‘hepatic steatosis’ OR steatohepatitis OR ‘nonalcoholic steatohepatitis’ OR ‘non-alcoholic steatohepatitis’ OR NASH)

Database

Query

PubMed

(“heart failure with preserved ejection fraction” OR “HFpEF” OR “E/A” OR “E/e” OR “E/e” OR “tissue doppler” OR “peak atrial longitudinal strain” OR “PALS” OR “atrial longitudinal strain rate” OR “left atrial strain” OR “left atrial stiffness” OR “left atrial” OR “left atrial volume” OR “left atrial volume index” OR “LAVi” OR “left atrial diameter” OR “diastolic dysfunction” OR “diastolic heart failure” OR “diastolic impairment” OR “diastolic”) AND (“nonalcoholic fatty liver disease” OR “non-alcoholic fatty liver disease” OR “NAFLD” OR “metabolic dysfunction fatty liver disease” OR “MAFLD” OR “fatty liver” OR “fatty liver disease” OR “steatosis” OR “liver steatosis” OR “hepatic steatosis” OR “steatohepatitis” OR “nonalcoholic steatohepatitis” OR “non-alcoholic steatohepatitis” OR “NASH”)

Embase

(‘heart failure with preserved ejection fraction’ OR HFpEF OR E/A OR E/e OR E/e' OR ‘tissue doppler’ OR ‘peak atrial longitudinal strain’ OR PALS OR ‘atrial longitudinal strain rate’ OR ‘left atrial strain’ OR ‘left atrial stiffness’ OR ‘left atrial’ OR ‘left atrial volume’ OR ‘left atrial volume index’ OR LAVi OR ‘left atrial diameter’ OR ‘diastolic dysfunction’ OR ‘diastolic heart failure’ OR ‘diastolic impairment’ OR diastolic) AND (‘nonalcoholic fatty liver disease’ OR ‘non-alcoholic fatty liver disease’ OR NAFLD OR ‘metabolic dysfunction fatty liver disease’ OR MAFLD OR ‘fatty liver’ OR ‘fatty liver disease’ OR steatosis OR ‘liver steatosis’ OR ‘hepatic steatosis’ OR steatohepatitis OR ‘nonalcoholic steatohepatitis’ OR ‘non-alcoholic steatohepatitis’ OR NASH)